CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (unaudited) - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Retained Earnings	AOCI (Loss), Net	Cumulative Effect, Period of Adoption, Adjustment	Total
Balance at Dec. 31, 2022	$ 109	$ 389,276		$ 240,810	$ (54,298)		$ 575,897
Balance (in shares) at Dec. 31, 2022	10,949,965
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock compensation plans	$ 3	3,962					3,965
Issuance of common stock under stock compensation plans (in shares)	285,190
Employee and non-employee stock-based compensation		2,222					2,222
Redemption of common stock for exercise of stock options and tax withholdings for restricted stock vesting		(1,336)					(1,336)
Redemption of common stock for exercise of stock options and tax withholdings for restricted stock vesting (in shares)	(23,881)
Net income				25,076			25,076
Other comprehensive income (loss)					4,166		4,166
Balance at Mar. 31, 2023	$ 112	394,124	$ (2,103)	263,783	(50,132)	$ (2,103)	607,887
Balance (in shares) at Mar. 31, 2023	11,211,274
Balance at Dec. 31, 2023	$ 111	395,871		315,975	(52,936)		659,021
Balance (in shares) at Dec. 31, 2023	11,062,729
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock compensation plans	$ 1						1
Issuance of common stock under stock compensation plans (in shares)	215,273
Employee and non-employee stock-based compensation		1,926					1,926
Redemption of common stock for exercise of stock options and tax withholdings for restricted stock vesting		(4,456)					(4,456)
Redemption of common stock for exercise of stock options and tax withholdings for restricted stock vesting (in shares)	(86,044)
Net income				16,203			16,203
Other comprehensive income (loss)					846		846
Balance at Mar. 31, 2024	$ 112	$ 393,341		$ 332,178	$ (52,090)		$ 673,541
Balance (in shares) at Mar. 31, 2024	11,191,958